Brief: Chemomab Therapeutics Names Jack Lawler Vice President Of Global Clinical Development Operations
04/01/2022 12:02
Jan 4 (Reuters) - Chemomab Therapeutics Ltd CMMB.O :
* CHEMOMAB THERAPEUTICS NAMES JACK LAWLER VICE PRESIDENT OF
GLOBAL
CLINICAL DEVELOPMENT OPERATIONS
Source text for Eikon: ID:nPn4Dp5TRa
Further company coverage: CMMB.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Chemomab Therapeutics
See all newsBrief: Chemomab Therapeutics Announces Second Quarter 2026 Financial Results And Provides Corporate Update
Chemomab Therapeutics Ltd expected to post a loss of 15 cents a share - Earnings Preview
Israel's Chemomab Q4 net loss narrows on lower R&D spend
Brief: Chemomab Therapeutics Announces Nebokitug Phase 2 Spring Trial Results
Brief: Chemomab Therapeutics Announces Third Quarter 2025 Financial Results And Provides Corporate Update